Business information provider Thomson Reuters, US, has announced that it has launched The Center for Comparative Effectiveness Research to help advance the quality and effective use of comparative effectiveness research (CER) in the US healthcare system.
Comparative effectiveness research evaluates medical treatments to determine which work best in real-world settings. To do this, researchers must assess a comprehensive array of health-related outcomes for diverse patient populations. According to Thomson Reuters, with nearly four decades of experience in this arena, the company is uniquely positioned to support CER initiatives with proprietary data, experienced researchers, and clinical decision support tools.
The new center will draw on unique information assets including the Thomson Reuters MarketScan Research Databases and clinical data repositories, built for research scientists in the life sciences and for hospital pharmacists. The Thomson Reuters MarketScan databases house integrated patient-level data for populations covered by commercial insurance, Medicaid, and Medicare supplemental plans. This information includes inpatient, outpatient, drug, laboratory, and other data reflecting real-world treatment patterns and costs.
Search for more Analytical Tools
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
